Affinity Asset Advisors, LLC - 28 May 2025 SCHEDULE 13G Report for Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO)

Filing Manager: Affinity Asset Advisors, LLC
Reporting Manager: Affinity Healthcare Fund, LP
Security: Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: LXEO
Shares outstanding: 54,864,581 shares
Disclosed Ownership: 4,252,005 shares
Ownership: 7.8%
Form type: SCHEDULE 13G
Filing time: 04 Jun 2025, 16:04:18 UTC
Date of event: 28 May 2025
Next filing: 29 Jan 2026
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Affinity Healthcare Fund, LP	7.8%	4,252,005	0	4,252,005	/s/ Andrew Weinstein	Andrew Weinstein
Affinity Asset Advisors, LLC	7.8%	4,252,005	0	4,252,005	/s/ Andrew Weinstein	Andrew Weinstein